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Abstract
Background: Blood flukes of the genus Schistosoma are platyhelminth parasites that infect 200 million people worldwide.
Digestion of nutrients from the host bloodstream is essential for parasite development and reproduction. A network of
proteolytic enzymes (proteases) facilitates hydrolysis of host hemoglobin and serum proteins.
Methodology/Principal Findings: We identified a new cathepsin L termed SmCL3 using PCR strategies based on S. mansoni
EST sequence data. An ortholog is present in Schistosoma japonicum. SmCL3 was heterologously expressed as an active
enzyme in the yeast, Pichia pastoris. Recombinant SmCL3 has a broad pH activity range against peptidyl substrates and is
inhibited by Clan CA protease inhibitors. Consistent with a function in degrading host proteins, SmCL3 hydrolyzes serum
albumin and hemoglobin, is localized to the adult gastrodermis, and is expressed mainly in those life stages infecting the
mammalian host. The predominant form of SmCL3 in the parasite exists as a zymogen, which is unusual for proteases. This
zymogen includes an unusually long prodomain with alpha helical secondary structure motifs. The striking specificity of
SmCL3 for amino acids with large aromatic side chains (Trp and Tyr) at the P2 substrate position, as determined with
positional scanning-synthetic combinatorial library, is consistent with a molecular model that shows a large and deep S2
pocket. A sequence similarity network (SSN) view clusters SmCL3 and other cathepsins L in accordance with previous large-
scale phylogenetic analyses that identify six super kingdoms.
Conclusions/Significance: SmCL3 is a gut-associated cathepsin L that may contribute to the network of proteases involved
in degrading host blood proteins as nutrients. Furthermore, this enzyme exhibits some unusual sequence and biophysical
features that may result in additional functions. The visualization of network inter-relationships among cathepsins L
suggests that these enzymes are suitable ‘marker sequences’ for inclusion in future phylogenetic analyses.
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Introduction
Proteases (proteolytic enzymes, peptidases) provide essential
functions in all life forms [1]. Proteases function as key elements
of parasitism including hatching, excystment, tissue/cell invasion,
nutrient acquisition and immune evasion [2,3]. For trematode
parasites causing diseases of medical and veterinary importance,
proteases operate at the host-parasite interface facilitating migra-
tion, digestion of host proteins and probably immune evasion [3,4].
Within the family Schistosomatidae, three major species infect
more than 200 million people worldwide [5]. After penetration of
human skin by aquatic larvae (cercariae), immature parasites
(schistosomula) migrate within the vascular system to the final
predilection site where females produce eggs upon maturation.
Parasite development and fecundity rely on nutrients ingested
from the host bloodstream. A network of proteases with differing
catalytic mechanisms ‘‘Clans’’ as described in the MEROPS
database (http://merops.sanger.ac.uk/) has been identified in the
schistosome gut and facilitates digestion of proteins to absorbable
peptides and amino acids [6–8]. For Schistosoma mansoni, the
component proteases thus far characterized include Clan CA S.
mansoni cathepsin B1 (SmCB1), SmCL1(SmCF) and SmCL2,
SmCC, a Clan CD asparaginyl endopeptidase (SmAE), a Clan AA
aspartic protease SmCD and a Clan MF leucine metallo-
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aminopeptidase [7,9]. Proteolytic networks associated with host
protein degradation and comprising the same protease clans have
been described for other parasitic platyhelminths [4] and are
conserved across phylogenetically diverse organisms such as
Plasmodium [10], nematodes [11] and arthropods [12].
Given their central importance in the biology of the parasite,
gut proteases have been tested as vaccine candidates for disease
prophylaxis [13,14] and are potential chemotherapeutic targets
[15,16]. As immunodominant antigens, some schistosome gut
proteases have been experimentally proven as serodiagnostic
antigens [17].
In this study, we have identified and characterized a new
cathepsin L in S. mansoni, SmCL3. From the original expressed
sequence tag (EST) [18] we have cloned and sequenced the full-
length open reading frame (ORF), and heterogeneously expressed
the enzyme in the yeast, Pichia pastoris. The hydrolytic activity and
specificity of the recombinant protease were characterized using
active site-directed affinity probes, peptidyl substrates and a
positional scanning-synthetic combinatorial library (PS-SCL).
Monospecific antibodies localized SmCL3 to the gut. Distinct from
SmCL1 and SmCL2, the N-terminus of the SmCL3 zymogen is
extended by approximately 30 amino acids, and the enzyme exists
primarily as a zymogen in the parasite rather than as a fully
processed mature enzyme. Sequence similarity clustering and
visualization using Cytoscape [19] places SmCL3 in the metazoan
cathepsin L cluster along with SmCL2 and cathepsins L from the
liver fluke, Fasciola spp.. This cluster is distinct from a second group
of cathepsins F that includes SmCL1 and those from other
trematode parasites such as Opisthorchis, Paragonimus and Clonorchis.
Materials and Methods
Schistosome material
S. mansoni (a Puerto Rican isolate) is maintained in the
laboratory by cycling between the freshwater snail, Biomphalaria
glabrata, and the golden hamster, Mesocricetus auratus. Hamsters are
maintained in barrier facilities as approved by the Institutional
Animal Care and Use Committee of the University of California
San Francisco (IACUC). All animal experiments were carried out
in accordance with the same protocols approved by the IACUC.
Infections with S. mansoni are initiated by subcutaneous injections
of 500–1000 cercariae. At 6–7 weeks post-infection, hamsters are
euthanized with intra-peritoneal injections of sodium pentobarbi-
tal (50 mg/kg), and adult worms harvested by reverse perfusion of
the hepatic portal system [20] in RPMI 1640 medium (Invitrogen).
Complete Medium 169 containing 5% fetal calf serum and 1%
ABAM (Antibiotics/Antimycotics: Sigma-Aldrich), was used to
maintain immature (schistosomula) and adult worms in vitro [21].
For preparation of schistosomula, cercariae were harvested from
the infected snails by light induction for 1 h, and chilled on ice in a
50 ml falcon tube. The water was poured off and replaced with
chilled incomplete Medium 169 (without serum) in preparation for
shearing of tails, a method modified from Colley and Wikel [22].
Cercariae were then passed back and forth 15 times between two
10 ml syringes connected by a double-headed 22 gauge needle.
Upon deposition into a 5 cm Petri dish, the lighter tails were
separated from heads by swirling and aspiration with a Pasteur
pipet. The nascent schistosomula were then collected and washed
three times in Incomplete Medium 169. After recovery from
hamsters, adult worms were washed 5 times in incomplete
Medium 169. Both schistosomula and adults were maintained in
complete Medium 169 under a 5% CO2 atmosphere at 37uC.
Miracidia (the stage infective to the snail) were prepared from eggs
trypsinized from infected liver tissue and hatched in freshwater.
Sequencing and cloning
A partial sequence encoding the cathepsin L3 was obtained from
the S. mansoni EST database [18]. Gene-specific primers were used
to verify the cathepsin L3 gene sequence. Briefly, S. mansoni mRNA
was isolated from adult worms using the FastTrack 2.0 isolation kit
(Invitrogen), and single strand cDNA was prepared using
Superscript III Reverse Transcriptase (Invitrogen) with an oligo-
dT18 primer. Purified cDNA was then used as template for PCR
using Taq Platinum polymerase (Invitrogen) and gene-specific
primers, SmCL3frd1 (59-GCCTGGCTCTGTAAATGTTGAG -
39) and SmCL3rev1 (59- CATATGGATAGGAAATCTCA-
GAATC -39). A 350 bp product was amplified and subsequently
cloned into pCR 2.1-TOPO cloning vector (Invitrogen) for
propagation in E. coli. Five positive clones were analyzed for
sequence verification.
Full-length cathepsin L gene was retrieved by rapid amplification
of cDNA ends (RACE) using the GeneRacer Kit (Invitrogen)
according to the manufacturer’s instructions. Gene specific primers
for 39 RACE were SmCL3 39RACE frd1 (59- GTTGCGTGGA-
TATAAAGTCACTAG -39) and SmCL3 39RACE frd2 (59-
GCTATCAGACATAAAGGGTCGAC -39). For 59RACE the
primers were SmCL3 59RACE rev1 (59- GTCGACCCTT-
TATGTCTGATAGC -39) and SmCL3 59RACE rev2 (59-
CTAGTGACTTTATATCCACGCAAC -39). Final amplicons
were cloned into pCR 2.1-TOPO cloning vector and sequenced.
To verify the entire ORF sequence, PCR incorporated
Platinum Taq polymerase, cDNA from adult worms and primers
directed to the 59 and 39 ends of the SmCL3 gene. The resulting
amplicons were cloned into pCR 2.1-TOPO cloning vector and
10 randomly selected positive E. coli clones were sequenced.
Stage-specific expression profiling of SmCL3 using
quantitative PCR
Total RNA was extracted from S. mansoni eggs, daughter
sporocysts extracted from hepatopancreases of snails patent for
infection, cercariae, newly transformed schistosomula (incubated in
vitro for 24 h), and adult worms using Trizol reagent according to
the manufacturer’s instructions (Invitrogen). The precipitation step
was omitted and RNA from the aqueous phase was purified using
Author Summary
Parasitic infection caused by blood flukes of the genus
Schistosoma is a major global health problem. More than
200 million people are infected. Identifying and character-
izing the constituent enzymes of the parasite’s biochemical
pathways should reveal opportunities for developing new
therapies (i.e., vaccines, drugs). Schistosomes feed on host
blood, and a number of proteolytic enzymes (proteases)
contribute to this process. We have identified and
characterized a new protease, SmCL3 (for Schistosoma
mansoni cathepsin L3), that is found within the gut tissue of
the parasite. We have employed various biochemical and
molecular biological methods and sequence similarity
analyses to characterize SmCL3 and obtain insights into its
possible functions in the parasite, as well as its evolutionary
position among cathepsin L proteases in general. SmCL3
hydrolyzes major host blood proteins (serum albumin and
hemoglobin) and is expressed in parasite life stages
infecting the mammalian host. Enzyme substrate specificity
detected by positional scanning-synthetic combinatorial
library was confirmed by molecular modeling. A sequence
analysis placed SmCL3 to the cluster of other cathepsins L in
accordance with previous phylogenetic analyses.
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the RNA Isolation Kit (Stratagene) according to the manufactur-
er’s instructions. The concentration of RNA was determined by
absorbance at 260 nm using a ND-1000 Spectrophotometer
(NanoDrop). Single-stranded cDNA was synthesized from 1 mg
of total RNA using SuperScript III reverse transcriptase (Invitro-
gen) and an oligo d(T)18 reverse primer according to the
manufacturer’s protocol, and the resulting cDNA was purified.
Quantitative PCR (qPCR) was carried out using the SYBR-green
MasterMix Plus Kit (Eurogentech) with 1 ml of purified cDNA and
each of 2 sets of forward and reverse primers (0.1 ml; 2.4 mM each;
Table S1) that had been designed using the Primer 3 software
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi, [23])
and designed to amplify 150–250 bp fragments.
Triplicate reactions were carried out in a final volume of 25 ml
in 96 well plates in a MX 3005P Real-Time PCR cycler
(Stratagene). The amplification profile consisted of an initial hot
start (95uC for 10 min) followed by 40 cycles comprising 95uC for
30 s, 55uC for 1 min and 72uC for 30 s. The ROX dye and S.
mansoni cytochrome C oxidase I (SmCyCOx) (GenBank
AF216698, [24]) were always used as a reference dye and
reference gene, respectively. Upon completion of the amplifica-
tion, the dissociation curve was examined for potential primer
dimerization. The cycle threshold (CT) values were averaged and
the standard deviation was determined. The relative expression
levels were calculated using the formula 2 2(SmCyCOx CT – Gene of
interest CT) [25].
Production of recombinant SmCL3 in Pichia pastoris
The primary amino acid sequence coding the SmCL3 gene was
analyzed by SignalP (http://www.cbs.dtu.dk/services/SignalP/;
[26]) to identify the predicted starting position of the proenzyme
which was then amplified with Pfx DNA polymerase (Invitrogen)
using the cloning primers SmCL3picZB frd, 59-GATACTGCA-
GATTCTGGTTTCAGAAAGTGGTC-39 (Pst I restriction site
underlined; note: the Kex 2 yeast protease processing site is placed
upstream in the expression pPICZ aB vector) and SmCL3picZB
rev, 59-TAAGCGGCCGCTCATACTAGAGGGTATGAAGCC-
GCACTGGCA-39 (Not I restriction site underlined, termination
codon in italic). Alternatively, a histidine-tagged reverse cloning
primer, SmCL3picZB revHis, 59-TAAGCGGCCGCTCACAT-
CATCATCATCATCATTACTAGAGGGTATGAAGCCGCA-
CTGGCA-39 (Not I restriction site underlined, termination codon in
italic, 66His-tag in bold), was used to amplify a C-terminal
histidine- tagged form (SmCL3-his) to facilitate subsequent
purification and concentration of the SmCL3 expression product.
The resulting PCR products were sub-cloned into the expression
vector pPICZ aB (Invitrogen), as previously described [27] and
sequences verified. Transformation of P. pastoris and protein
expression were carried out as described previously [27,28].
Purification of recombinant SmCL3
The induction yeast medium containing recombinant enzyme
was filtered (0.45 mm), lyophilized and stored at 220uC until use.
The powder was resuspended to 10% of the induction volume,
and desalted using PD-10 columns (GE-Healthcare) and eluted in
50 mM sodium phosphate (pH 6.0) for non his-tagged enzyme, or
50 mM sodium phosphate, pH 7.5, 500 mM NaCl for SmCL3-his
SmCL3-his was purified further on a HisTrap 5 ml column (GE-
Healthcare). The column was equilibrated with 50 mM sodium
phosphate, 500 mM NaCl, pH 8.0. Enzyme sample was loaded
and the column washed with 25 ml of 50 mM sodium phosphate,
500 mM NaCl, 20 mM imidazole, pH 6.0 and eluted in same
buffer containing 500 mM imidazole. Salt and imidazole were
then removed by buffer exchange on an Amicon Ultra 10 kDa
spinning column by 5 wash and centrifugation steps into 50 mM
citrate, 100 mM sodium phosphate buffer, pH 6.0.
The presence of active recombinant enzyme was verified by
protease activity assay (see Protease activity assays) and by SDS-
PAGE gels with protein visualized either with iodinated clan CA
affinity label 125I-DCG-04 (see Active site labeling) or with SafeStain
protein dye (Invitrogen). The cleavage sites used to generate the
active recombinant enzyme were identified by N-terminal protein
sequencing (Protein and Nucleic Acid Facility, Stanford University).
The recombinant enzyme was stored at 220uC.
To determine glycosylation status, recombinant SmCL3 activity
was inhibited for 30 min at RT with 10 mM K11777 and
deglycosylated using endoglycosidase H (Endo-H, Roche) accord-
ing to the manufacturer’s protocol. Samples were then resolved by
15% SDS-PAGE.
Active site labeling
The specific irreversible affinity probe for Clan CA cysteine
proteases, 125I-DCG-04 [29] was used to label the active site of
recombinant SmCL3 at pH 6.0, as previously described [30].
Prior to radiolabeling, control samples were incubated for 20 min
in the presence of 10 mM of the Clan CA cysteine protease
inhibitor E-64 (L-trans-epoxysuccinyl-leucylamide-(4-guanido)-bu-
tane; Sigma) or preheated at 70uC. Labeled SmCL3 samples were
resolved by SDS-PAGE (15% Tris-HCl Criterion gel; Biorad) and
visualized by autoradiography using a Typhoon Trio 8600
Variable Mode Imager (GE Healthcare).
Protease activity assays, kinetics and inhibition constants
Proteolytic activity was measured with the synthetic fluorogenic
dipeptidyl substrate Z-Phe-Arg-AMC (benzyloxycarbonyl-phenylala-
nylarginine-7-amido-4-methylcoumarin; Bachem). Assays were per-
formed in black 96-well plates as described previously [28]. Briefly,
recombinant SmCL3 enzyme was pre-incubated for 10 min at RT
(room temperature) in 50 mM citrate, 100 mM sodium phosphate,
pH 3.0–8.0 or 100 mM glycine, pH 7.0–11.0. All buffers contained
100 mM NaCl and 2 mM dithiothreitol (DTT) in a final volume of
100 ml. The reactions were started by adding 100 ml of the same
buffer solution containing 40 mM Z-Phe-Arg-AMC. Release of free
AMC was measured at excitation and emission wavelengths of 355
and 460 nm, respectively, in a Labsystems Fluoroskan II fluorescent
plate reader (Thermo Electron Corporation).
For pH stability assays, recombinant SmCL3 samples were
incubated in 50 mM citrate, 100 mM sodium phosphate, 2 mM
DTT, pH 3.0–8.0 at 37uC for 1 h. Enzyme activities were
analyzed at pH 6.0 using fluorescent dipeptidyl substrate Z-Phe-
Arg-AMC and active site labeling with 125I-DCG-04.
The Km value and kcat (turnover rate) for SmCL3 with Z-Phe-
Arg-AMC were determined by nonlinear regression analysis Prism
4 (GraphPad). Rates were obtained from substrate concentrations
(0.2–150 mM) with a fixed enzyme concentration of 3 nM. Assays
were performed in black 96-well plates in 50 mM citrate, 100 mM
sodium phosphate, pH 6.0 at a final volume of 200 ml. Release of
free AMC was measured at 25uC in a Flex Station fluorescent
plate reader (Molecular Devices).
Kinetic analyses with irreversible cysteine protease inhibitors
were performed as previously described [31]. Enzyme (,3 nM) in
100 mL 50 mM citrate, 100 mM sodium phosphate, pH 6.0 (see
above), was added to inhibitor dilutions in 100 mL of the same
assay buffer containing 25 mM Z-Phe-Arg-AMC. Progress curves
were recorded for 5 min in the Flex Station fluorescent plate
reader at 25uC (less than 5% of substrate consumed) over a range
of dilutions (0.5, 0.4, 0.3, 0.2, 0.1, 0.05, and 0 mM) of inhibitors
the cysteine protease inhibitors E-64 or K11777 (N-methyl
SmCL3 - S. mansoni Gastrodermal Protease
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piperazine-ureaphenylalanyl-homophenylalanyl-vinylsulfone-ben-
zene [32,33] dissolved in DMSO (final DMSO in assay was 0.5%).
Inhibitor dilutions giving simple exponential progress curves over
a wide range of kobs (first order observed inhibition constant) with
r^2 values $ to 0.9 were used to determine kinetic parameters.
The value of kobs, the rate constant for loss of enzyme activity, was
determined from an equation for pseudo first order dynamics
using Prism4 software (GraphPad). When kobs varied linearly with
inhibitor concentration, kass (complex formation constant) was
determined by linear regression analysis [34]. If the variation was
hyperbolic, indicating saturation inhibition kinetics, kinact (maximal
inactivation rate constant) and Ki (inhibition constant) were
Figure 1. Multiple alignment of SmCL3 (ABV71063) with orthologous SjCL3 from S. japonicum (AAW27185) and characterized
S.mansoni cathepsin L-like genes (SmCL2, CAA83538; SmCL1, Q26534). The catalytic triad residues (C, H and N) are marked in bold and
underlined. Glutamine involved in the formation of the oxyanion hole and preceding the catalytic cysteine is underlined. Potential N-linked
glycosylation sites are shaded in grey. The predicted starts of the pro-peptide and catalytic domains are highlighted in bold and shaded in yellow,
and by an arrow, respectively. Type I-29 protease inhibitor is underlined. ERFNIN and GNFD motifs present in the pro-peptide are overlined with
amino acid residues highlighted in bold italic. Six cysteines forming three putative disulfide bonds that are present the catalytic domain are marked
by bold overlines. Residues forming the critical S2 subsite specificity pocket are in bold.
doi:10.1371/journal.pntd.0000449.g001
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determined from an equation describing a two step irreversible
inhibitor mechanism (kobs = kinact [I]o/([I]o+Ki* (1+[S]o/Km))) and
nonlinear regression analysis using Prism. 4.
Incubation of recombinant SmCL3 with protein
substrates
Recombinant SmCL3 (,100 nM) was incubated overnight at
37uC with bovine albumin or bovine hemoglobin (1 mg/ml;
Sigma) in 50 mM citrate, 100 mM sodium phosphate, 2 mM
DTT, pH 3.0–10.0. After incubation, a 20 ml sample was resolved
by 10% Bis-Tris NuPage Novex gel with MES buffer running
buffer (Invitrogen).
Subsite specificity profiling by positional scanning-
synthetic combinatorial library (PS-SCL)
PS-SCL were employed as previously described [35]. All 20
amino acids were incorporated in tetrapeptides where cysteine was
omitted and norleucine included. Assays involving either SmCL3
or SmCL3-his were carried out in black 96-well microtiter plates
at pH 6.0, as described previously [35,36]. Release of 7-amino-4-
carbamoylmethylcoumarin (ACC) was measured in a Perkin-
Elmer LS50B luminescence spectrometer with excitation and
emission wavelengths set to 380 and 460 nm, respectively.
Production of mouse polyclonal antibodies to
recombinant SmCL3
One mg of purified recombinant SmCL3-his was resolved by
SDS-PAGE (12% Tris-HCl Criterion gel; Biorad). Gels were briefly
stained in SimplyBlue Safe Stain to visualize the SmCL3 protein
band and then washed with water. The protein band was excised
and homogenized in sterile saline using a glass homogenizer. Five
Swiss-Webster mice were injected with a 100 ml mixture of antigen
and adjuvant 4 times at 14 day intervals. The first injection was
administered intraperitoneally in Freunds Complete Adjuvant
(Sigma) in a ratio 3:1. Three subsequent subcutaneous injections
contained antigen in TiterMax Gold adjuvant (Sigma) at a 2:1 ratio.
For control sera, blood samples were withdrawn from mice
receiving acrylamide samples alone. Seven days after the last
injection, mice were euthanized and exsanguinated. After clotting,
serum was separated from blood cells and then the IgG fraction
isolated using a HiTrap Protein G column (GE-Healthcare),
according to the manufacturer’s protocol.
Immunoblotting
For immunoblotting, S. mansoni soluble protein extracts were
prepared by sonication in 50 mM citrate, 100 mM phosphate,
pH 5.0 over an ice bath in the presence of Protease Inhibitor
Cocktail (Sigma). After brief centrifugation at 8 000 g for 5 min at
4uC, supernatants containing soluble proteins were collected.
Extracts (20 mg per well) and recombinant SmCL3 were resolved
by SDS-PAGE (15% Tris-HCl Criterion gels) and transferred onto
a PVDF membrane (Biorad). Membranes were blocked overnight
at 4uC in 5% non-fat dry milk in Tris-buffered saline containing
0.1% Tween 20 (TBS-T) and washed 365 min in TBS-T. After
washing, membranes were incubated for 1 h with anti-SmCL3 or
control purified polyclonal IgG (1:1000) in TBS-T. Membranes
were then washed 3615 min in TBS-T and incubated for 1 h with
anti-mouse IgG-HRP conjugate (GE Healthcare) at a dilution of
1:2000. After washing in TBS-T 3615 min, followed by a single
wash in TBS for 5 min, membranes were developed using an
enhanced chemiluminescent kit (ECL Western Blotting Detection
Reagents, GE Healthcare) according to the manufacturer’s
instructions. Immunoreactivity was visualized by exposure to the
SuperRX Medical X-Ray Film (Fuji).
Figure 2. Recombinant SmCL3 expressed in Pichia pastoris. (A)
SmCL3 after purification by nickel-affinity chromatography was resolved
by SDS-PAGE analysis (4–20%) and stained by SimplyBlue SafeStain.
Lanes A and B represent recombinant enzyme before and after
treatment with Endo-H glycosidase, respectively.
doi:10.1371/journal.pntd.0000449.g002
Figure 3. Active site labeling of recombinant SmCL3 by the
Clan CA cysteine protease affinity label 125I-DCG-04. (A) Purified
enzyme incubated with 125I-DCG-04. In order to confirm the specificity
of the probe to the protease active site, enzyme was (B) incubated prior
to labeling with the Clan CA inhibitor E-64, or (C) preheated at 70uC.
Sample not incubated with the affinity probe (D). Samples were
analyzed by SDS-PAGE (15%) and visualized in phosphor image mode.
doi:10.1371/journal.pntd.0000449.g003
SmCL3 - S. mansoni Gastrodermal Protease
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Immunolocalization
Perfused adult S. mansoni worms were fixed in 0.1%
glutaraldehyde in PBS, pH 7.4 at RT for 2 h, washed 3615
in PBS, pH 7.4 and stored at 4uC prior to use. Samples were
then embedded in JB-4 (Polyscience), sectioned at 2.5 mm,
placed on glass slides and dried at 60uC for 5 min. Incubation
with mouse control or anti-SmCL1 IgG antibodies at 1:200
dilutions in TBS-T and secondary Alexa Fluor 594 anti-mouse
IgG (Invitrogen) was carried out as described [37]. Localization
was observed using a laser scanning microscope LSM 510
META (Carl Zeiss).
Size exclusion chromatography of S. mansoni soluble
protein extract
Soluble extract from adult worms was prepared as described
above. The extract was size fractioned using pre-equilibrated
column Superdex 200 (GE- Healthcare) according to manufac-
ture’s instructions. Eluted fractions were resolved by SDS-PAGE
(15% Tris-HCl Criterion gel, Biorad) and transferred onto a
PVDF membrane (Biorad) and SmCL3 was detected by Western
blot analysis.
3D structural modeling of SmCL3
The SmCL3 protein sequence was used as a query in a web-
based blastp at http://blast.ncbi.nlm.nih.gov [38] search of the
Protein Data Bank (PDB; http://www.rcsb.org/pdb) using the
default setting of filtering low-complexity regions. The fourth best
hit was used as the template for modeling because this hit had a
good E-value and also included an inhibitor complexed with the
protein, which improves modeling results. The template was human
cathepsin V complexed with vinyl sulfone inhibitor K11777
[32,33], pdb ID 1FH0, (with identical chains A and B, solved to
1.6 A˚ resolution). The BLAST alignment of SmCL3 and 1FH0 had
59% sequence identity (135/227 residues), E-value = 2e-74. The
Figure 4. pH optimum and stability of recombinant SmCL3. (A) Using the fluorogenic peptidyl substrate, Z-Phe-Arg-AMC, SmCL3
demonstrates a broad pH optimum. Enzyme was assayed in 50 mM citrate, 100 mM sodium phosphate buffer (#) or 100 mM glycine buffer (N), both
containing 2 mM DTT. (B) Peptidolytic activity was measured with Z-Phe-Arg-AMC in 50 mM citrate, 100 mM sodium phosphate, 2 mM DTT, pH 6.0,
after preincubation under different pH conditions in 50 mM citrate, 100 mM phosphate for 30 min (black bars), 1 h (dotted bars) and 3 h (striped
bars). Samples that had been incubated for 3 h were also labeled with the active site affinity probe 125I-DCG-04 (amount of active enzyme visualized
corresponds to the amount measured with Z-Phe-Arg-AMC).
doi:10.1371/journal.pntd.0000449.g004
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alignment from the BLAST search was used with the homology
modeling program PLOP [39]. In order to show the active site as a
substrate would likely bind, views of the model were generated in
Chimera [40] as follows: The template 1FH0, chain A, was aligned
to the SmCL3 model in Chimera using the Matchmaker tool. The
template was then hidden except for the inhibitor. The catalytic
Cys172 and His317 were colored yellow and blue, respectively. The
residues in the S2 binding pocket that are #5 A˚ from the inhibitor
are shown in ball-and-stick format. The predicted residues in this
pocket are identical to those in the 1FH0 template (cathepsin V)
except for one residue which is Leu216 in SmCL3 (colored light
green) and Phe69 in 1FH0. Other important active site residues
Gln166 and Asn337 aligned closely with the same corresponding
residues in 1FH0 (not highlighted in the model).
To analyze SmCL3 prodomain structure, protein sequence was
also imported into the protein modeling program interface
Maestro (Maestro 8.5207, Schrodinger, LLC), and the secondary
structure prediction program PSIpred [41] run on the sequence
through the Maestro interface using the Prime application (Prime
2.0208, Schrodinger, LLC). Secondary structure prediction
programs such as PSIpred are about 75% accurate (http://
cubic.bioc.columbia.edu/eva/sec/res_sec.html).
Sequence similarity network (SSN) depicting relationships
among SmCL3 and other cathepsin L-like genes
SmCL3 was queried against the UniRef100 database (http://
www.ebi.ac.uk/uniref/) [42] of non-redundant protein sequences
using the program blastp [38]. A perl script was then used to select
1025 sequence hits scoring at E-value#1e230 and where the
alignment length was at least 80% of the query length. The
sequences were filtered to a set of 297 sequences #60% identical to
each other using the program CD-HIT [43]. An all vs. all blastp
search of these representative sequences was then performed to find
sequence similarity relationships between all 297 proteins. Perl scripts
were used to parse the species names from the UniRef IDs and to key
species to class using data from NCBI Taxonomy (http://www.ncbi.
nlm.nih.gov/Taxonomy). The resulting data of sequence similarity
relationships and node labels were formatted, colored by class and
visualized using sequence similarity networks (SSNs) for visualization
of relationships across diverse protein superfamilies [44] in the
‘organic’ layout with Cytoscape v2.4.1 [19]. An E-value cutoff
threshold of 1e260 was used for drawing edges between sequences.
Cytoscape is an open source bioinformatics software platform for
visualizing many types of biological networks (http://www.cytoscape.
org/index.php). In the ‘organic’ view, each representative sequence is
displayed as a colored ‘‘node’’ with lines connecting nodes signifying a
BLAST E-value relationship better than the cutoff value. The 247
nodes that formed clusters are shown; more highly interconnected
nodes have shorter edges than less well-connected nodes. To aid
interpretation of the output, the nodes were also colored to
correspond to a super kingdom classification proposed by Simpson
and Roger [45]. For details about included gene sequences see
supporting Cytoscape data (Fig. S1; Note: you have to download
Cytoscape v2.4.1 program at http://www.cytoscape.org/index.php).
Results
SmCL3—a cathepsin L with unusual sequence features
PCR strategies based on EST information [18] led to the
amplification, sequencing and characterization of a novel cathepsin
L gene in S. mansoni that we term SmCL3 in accordance with the
previously used nomenclature [7,46]. PCR screening did not identify
other gene isoforms. The open reading frame (ORF) consists of
1113 bp (370 amino acids; GenBank accession EU022371) that
encodes a pre-proenzyme (Fig. 1). The signal leader sequence was
predicted to have a length of 16 amino acid residues. The 130 residue
pro-peptide sequence was predicted from a multiple sequence
alignment using BLASTP 2.2.18 (http://www.ncbi.nlm.nih.gov/
blast/) [38]. Mw/pI values, calculated by the Compute pI/Mw
program (http://www.expasy.org) [47], are 41.2/6.5, 39.4/6.5, and
24.1/4.9 kDa for the full length, zymogen and mature proteins,
respectively. Cys172, His317, Asn337 form the protease’s catalytic triad
that is essential for peptidolytic activity. Gln168, a residue expected to
be involved in the formation of the oxyanion hole, is present. The
mature (catalytic) domain has 3 putative disulfide bonds typical of
other cathepsin L enzymes [48]. Potential N-linked glycosylation sites
are at positions 194 and 252 (Fig. 1).
Figure 5. Hydrolysis of bovine serum albumin and hemoglobin
by SmCL3. Recombinant SmCL3 (,100 nM) was incubated with serum
albumin (A) or bovine hemoglobin (B) overnight at 37uC in 50 mM
citrate, 100 mM sodium phosphate (pH 3.0–7.0) or 100 mM glycine
(pH 8.0–10.0.) buffers containing 2 mM DTT. Some cleavage can be
observed across the whole pH spectrum. Cleavage was optimal for both
protein substrates between pH 4.0–7.0. (C) Samples incubated at
pH 5.0, but without the presence of protease.
doi:10.1371/journal.pntd.0000449.g005
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Compared to typical cathepsins L, the pro-peptide of SmCL3 is
unusually long with an N-terminal extension of approximately 30
amino acids, similar to the S. japonicum ortholog (SjCL3; GenBank
AAW27185; [49]) and two more distant Clonorchis sinensis
cathepsins L (Genbank ABK91809, ABJ89815; Hu et al,
unpublished). Also, an asparagine residue, present in the pro-
peptide of previously characterized S. mansoni proteases and a site
of trans-activation by asparaginyl endopeptidases [30,50] is absent
in SmCL3. Like other cathepsins L, the pro-peptide contains a
type I-29 protease inhibitor motif [51,52] (Fig. 1). A variant of the
ERFNIN motif, found in other cathepsin L family pro-peptides
[53], is present as ERFNMN. A second motif, GNFD, which is
involved in intramolecular processing of other Clan CA proteases
[54], is also present in the pro-peptide (Fig. 1). The elongated
prodomain is not random coil but is predicted to be alpha helix by
protein modeling using Maestro.
SmCL3 is expressed as a fully processed and activated
enzyme by P. pastoris
SmCL3 was successfully expressed in the yeast P. pastoris, fully
processed and activated; i.e., without the presence of the pro-
peptide. Typical yields of recombinant SmCL3 were 30–50 mg/l of
expression media. Peptidolytic activity was evident with or without
the C-terminal 66His-tag using the dipeptidyl substrate Z-Phe-Arg-
AMC. As judged by kinetic analyses and assays with the positional
scanning synthetic combinatorial library (see SmCL3 positional
scanning below), the presence of this 66His-tag had no effect on
catalysis and this expression variant was, therefore, used for
subsequent studies. The Clan CA specific inhibitor, E-64,
eliminated peptidolytic activity, thus verifying the catalytic mech-
anism as consistent with cysteine proteases. Using SDS-PAGE, the
estimated molecular mass was,32–34 kDa which decreased to 28–
30 kDa after enzymatic deglycosylation (Fig. 2) consistent with the
use of at least one of the two potential glycosylation sites by Pichia.
Purified SmCL3 was labeled with the cysteine protease affinity
probe, 125I-DCG-04 (Fig. 3) and cleaved gelatin on zymogram gels
(not shown). Though the enzyme was expressed as fully active, some
processing heterogeneity was noted by N-terminal protein sequenc-
ing of the purified expression product. The most abundant cleavage
site (as predicted above) was after the Lys153 (HTKQLPS, Fig. 1). A
less abundant and slower migrating protein species was also
produced by Pichia (Fig. 3). 125I-DCG-04-labeling confirmed the
band as a variant form of SmCL3 (Fig. 3). We attempted to
sequence this minor band but without success.
SmCL3—proteolytic activity and specificity
SmCL3 is catalytically active over a broad pH range. Hydrolysis
of Z-Phe-Arg-AMC displayed a bell-shaped pH profile from
pH 3.0–11.0 with optimal activity around pH 6.5 (Fig. 4A).
Bovine albumin and bovine hemoglobin were degraded: albumin
was partially hydrolyzed with a pH optimum around 6.0 (Fig. 5A);
hydrolysis of hemoglobin was complete at pH 4.0–6.0 with partial
hydrolysis at lower and higher pH values (Fig. 5B). These pH
dependencies for activity correlated with the enzymatic stability of
SmCL3 between pH 4.0–6.0 as measured with both Z-Phe-Arg-
AMC and 125I-DCG-04 (Fig. 4B). No loss of activity was recorded
after incubation of enzyme for 30 min, 1 and 3 h. However, at
other pH values, a time dependent decrease in activity was
Figure 6. P1–P4 specificity profile of SmCL3 using positional scanning-synthetic combinatorial libraries. The P2 substrate position
shows the strongest preference for specific amino acid types with large hydrophobic residues being most favored. Y-axis represents % of preference
for the particular amino acid when 100% represents most preferred residue.
doi:10.1371/journal.pntd.0000449.g006
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measured. Therefore, the difference in profiles between the
activity and stability experiments is possibly due to the instability
of the enzyme at pH values equal to or greater than 7.0.
Kinetic constants obtained for SmCL3 with Z-Phe-Arg-AMC
were: Km = 20.2 mM and kcat/Km = 410 mM21 s21. Inhibition
constants (kobs at 1 nM of inhibitor) measured for SmCL3 with E-
64 and K11777 were 26.5 and 140 nM21 s21, respectively.
Consistent with other Clan CA proteases [35], SmCL3 prefers
the basic amino acids lysine and arginine at the P1 subsite
position (Fig. 6). At P2, the enzyme prefers hydrophobic amino
acids, especially bulky aromatic residues. Upon a search of the
literature involving PS-SCL assays, the P2 preferences of SmCL3
was found to closely resemble those of human cathepsin V [35],
a cathepsin L-like protease. In particular, there is an overriding
preference for tryptophan and equal preference for phenylalanine
and leucine in the P2 sites of both enzymes. Screening at P3 and
P4 revealed greater promiscuity. Notably, SmCL3 is able to
accept aspartic acid at P2 and P3 positions, which is similar to
human cathepsin F [35].
The 3D structural model of SmCL3 identifies a large and
deep S2 subsite pocket and secondary structure
predictions indicate a helical type prodomain
For the three-dimensional model of SmCL3, the X-ray
crystallographic structure of human cathepsin V complexed with
a peptidyl vinyl sulfone inhibitor, K11777, was used as template.
We used this template because of its high percentage identity
(59%) to SmCL3 and because the structure was solved with an
inhibitor in the active site thereby likely making the modeling of
the active site more accurate. From the structure-based alignment,
the predicted interaction of the modeled structure with K11777 is
depicted in Fig. 7. The predicted residues in the S2 binding pocket
of SmCL3 are identical to those in cathepsin V with the exception
of a Leu residue (Leu216) which is phenylalanine (Phe69) in
Figure 7. Structural model of SmCL3 in complex with the peptidyl vinyl sulfone inhibitor, K11777. The inhibitor is shown in red and
orange; the moiety that interacts with the S2 pocket is in orange. The catalytic Cys172and His317 residues are colored yellow and blue, respectively.
The predicted residues in the deep S2 binding pocket are identical to those in human cathepsin V (used as a template for the model) except for a
leucine residue (Leu216, colored light green).
doi:10.1371/journal.pntd.0000449.g007
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cathepsin V. This substitution enlarges what is already a deep and
wide pocket, and consistent with the results from the PS-SCL,
appears well adapted to accept the side chains of bulky aromatic
residues, such as tryptophan, tyrosine and phenylalanine.
The prodomain region was lacking in the template and so is not
included in the model. However, secondary structure prediction
indicates that five helices are likely to form in the SmCL3
prodomain (not shown).
SmCL3 is mainly expressed as a zymogen in the gut of
the parasite stages infecting the definitive host
Quantitative PCR demonstrated that SmCL3 is predominantly
expressed in those developmental stages infecting the mammalian
host (Fig. 8A), a result that is in accord with the protein expression
profile as shown by immunoblots with specific polyclonal anti-
SmCL3 IgG (see below). Most mRNA for SmCL3 was detected in
transformed schistosomula in vitro, and adult male and female
worms. Expression profiling by qPCR indicated that SmCL3
mRNA is 50 to 1000 fold less abundant relative to previously
described gut-associated proteases in S. mansoni adults [7,8]
(Fig. 8B). SmCL3 mRNA is also less abundant than that of the
tegumental/parenchymal SmCB2 [27] (more than 100-fold), but
is found in greater quantities than the endoplasmatic reticulum
protease, SmER-60 [55] (more than 10-fold).
By immunobloting with specific polyclonal anti-SmCL3 IgG
(Fig. 9), native SmCL3 was detected in extracts of both adults and
newly-transformed schistosomula 1 h after in vitro transformation.
Weaker reactivity was detected in extracts of eggs and no reaction
was found in extracts of miracidia and cercariae. Control mouse
IgG antibodies were non-reactive throughout (not shown).
Unlike the immuno-reactivity observed at approximately
30 kDa for the recombinant enzyme (Fig. 9, lanes 1 and 2), the
major reactive band in schistosome extracts migrated with a mass
of approximately 40 kDa (Fig. 9, lanes 3, 4 and 7), a mass that
corresponds to that of the SmCL3 zymogen. Attempts to process in
trans pro-SmCL3 within extracts using other recombinant
proteases such as SmCB1 [30] and a asparaginyl endopeptidases
from tick [36] or S. mansoni [30] failed, as did incubation of worms
extracts overnight at 37uC in an effort to endogenously process the
zymogen (not shown). The data suggest, therefore, that SmCL3 is
present in its major form as a zymogen rather than as mature
catalytically active enzyme. As judged by immunoblotting, size
Figure 8. Developmental regulation of SmCL3 transcription and transcript abundance relative to other S. mansoni proteases. (A) The
highest CT value (which was 0.94) was set as 100%. (B) In the adult worms (mixed sexes) CT levels of mRNA encoding SmCL3 (dotted bar) were
compared with gut-associated proteases (black bars) and two other proteases, the tegumental/parenchymal SmCB2 and endoplasmatic reticulum-
associated SmER-60 (striped bars). Standard deviations were never greater than 0.3 for initial CT values. For enzyme nomenclature [7,46] see
Introduction.
doi:10.1371/journal.pntd.0000449.g008
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exclusion chromatography of S. mansoni adult soluble protein
extracts separated the putative SmCL3 zymogen (Fig. 10, fractions
24–27) from the immunoreactive protein species of 30 kDa – the
possible mature enzyme (fractions 30–32), and of 13 and 11 kDa –
possible SmCL3 fragments (fractions 35–38).
SmCL3 was not detected by specific polyclonal IgG in
excretory/secretory (E/S) products of adult worms maintained
in culture medium. Nevertheless, SmCL3 was detected by
antibody in the regurgitant when adult worms were induced to
regurgitate in water (data not shown).
SmCL3 was localized to the gastrodermis of both adult sexes
with some reaction in the female vitellaria using confocal
microscopy with mouse anti-SmCL3 IgG and Alexa Fluor 594
secondary antibodies (Fig. 11A, 11C, and 11D). No reaction was
observed in the tegument and parenchyma. No staining was
observed with control mouse polyclonal IgG (Fig. 11B).
Sequence similarity clustering of cathepsins L
recapitulates taxonomic kingdom groupings with SmCL3
among the Opisthokonta
A network view of primary protein sequence similarity
relationships among cathepsin L type enzymes was generated
using the software Cytoscape [19]. Each sequence is represented as
a square node, except for cathepsin L sequences from platyhel-
minths which are indicated by circular nodes and those
representing Trematoda are enlarged circular nodes (Fig. 12). Of
immediate interest is that the clustering of cathepsin L sequences
agrees closely with the taxonomic organization of the kingdoms of
life into six supergroups [45]: Opisthokonta, Plantae, Chromal-
veolata, Amoebozoa, Rhizaria and Excavata (Fig. 12). SmCL3
(white circular node) is found within a large cluster of closely
related invertebrate (light blue squares) and vertebrate metazoan
(dark blue squares) cathepsins L that together make up the super
kingdom Opisthokonta. This large cluster also includes the S.
japonicum ortholog, SjCL3, two C. sinensis cathepsin L genes, the
SmCL2 gene and related cathepsins L from Fasciola gigantica and F.
hepatica. The cluster is distinct from a cluster of cathepsins L that is
restricted to the Plantae super kingdom, an organizational level of
primary plastid endosymbionts comprising plants, green and red
algae. More disparate clusters of cathepsin L sequences are found
in the super kingdom Chromalveolata (secondary symbionts;
contains apicomplexan parasites such as Toxoplasma and Cryptospo-
ridium), the Amoebozoa (includes the parasite Entamoeba histolytica).
Another compact cluster displayed in Fig. 12 is entirely composed
of baculovirus cathepsin L-like genes (encircled black) and is least
connected to the other clusters.
The Cytoscape view also resolves a cluster of sequences that is
enriched in cathepsins F and W, which are subtypes of cathepsin L
(encircled in orange). This cluster includes sequences of greater
phylogenetic diversity including SmCLl (aka SmCF) [7], cathep-
sins F from Opisthorchis viverrini, Clonorhis sinensis, Paragonimus
westermani and Metagonimus yokogawai, and Excavata parasitic
kintetoplastid cathepsins. Finally, a small cathepsin H cluster,
another subtype of cathepsin L (encircled in green) is resolved that
from the clusters containing cathepsins L and F/W. For sequence
details see supporting Cytoscape data (Fig. S1; Note: after
downloading Cytoscape).
Discussion
Growth, maturation and fecundity of the schistosome parasite in
the mammalian host rely on nutrients ingested from the host
bloodstream. A number of proteases are expressed in the gut of S.
mansoni and are involved in the degradation of hemoglobin and
serum proteins [7,8]. This multienzyme network includes two
cathepsins L, SmCL1 (aka SmCF) and SmCL2 [7,46,56].
Although sequences for other cathepsins L exist in the EST
Figure 9. Detection of SmCL3 by Western blot in soluble S.
mansoni extracts using mouse polyclonal IgG antibodies.
Recombinant enzyme or soluble S. mansoni protein extracts (each
20 mg) were resolved by SDS-PAGE (15%) and electroblotted onto PVDF
membrane. IgG purified antibodies reacted with (1) deglycosylated
recombinant protein, (2) glycosylated protein, soluble extracts of (3)
adults, (4) eggs and (7) 1 day old in vitro transformed schistosomula.
Extracts of (5) miracidia and (6) cercariae did not react.
doi:10.1371/journal.pntd.0000449.g009
Figure 10. Western blot analysis of SmCL3 in adult S. mansoni
soluble protein extract after size exclusion chromatography.
Several protein species were detected after size exclusion chromatog-
raphy. Two species corresponding to the molecular mass of the
zymogen are present in fractions 24–27. A protein species of 28 kDa
corresponding to the mass of the mature enzyme is recognized in
fractions 30–32. Two species of 15 and 13 kDa was detected in
fractions 35–38. R - recombinant glycosylated SmCL3 electroblotted as
a control; start - soluble protein extract (,60 mg) before size exclusion
chromatography.
doi:10.1371/journal.pntd.0000449.g010
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datasets [18] and in first pass assembly of the genome (Mashiyama,
Caffrey, Sajid, unpublished), nothing is known about their
contribution to schistosome metabolism. Here, we identified,
heterologously expressed and characterized a novel gut-associated
cathepsin L that we term SmCL3. A sequence for an ortholog in S.
japonicum (SjCL3) also exists (GenBank AAW27185; [49]).
SmCL3 possesses sequence characteristics consistent with those
of other cathepsins L. These include six Cys residues forming three
disulphide bonds [48], an active site catalytic triad of Cys, His and
Asn [57], the residue Gln168 involved in the formation of the
oxyanion hole, a pro-peptide that contains an I29 inhibitor family
sub-domain and a variation of the ERFNIN motif (ERFNMN)
that is typical for cathepsins L [53]. This motif, together with the
motif GNFD [54], is probably involved in intra-cellular trafficking
and processing.
Other sequence features of SmCL3 are more unusual, especially
when compared to other helminth cysteine proteases associated
with the gut. First, an Asn residue, found between the pro-peptide
and mature domain of other gut cathepsins in Schistosoma [30,50]
and fasciolids [50,58], and demonstrated to be a processing site for
Figure 11. Localization of SmCL3 in adult worms by immunofluorescence confocal microscopy. Mono-specific mouse IgG and
subsequent amplification with Alexa Fluor 594 anti-mouse IgG were used to localize SmCL3. A strong reaction is detected in the gastrodermis of S.
mansoni males and females (A). In males (C), the reaction is apparently exclusive to the gastrodermis whereas in females (D) a reaction is also noted
in the vitellaria (white arrows). Control mouse IgG antibodies did not react even after over-exposure of the image (B).
doi:10.1371/journal.pntd.0000449.g011
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pro-cathepsin activation by an asparaginyl endopeptidase (AE)
[30], is absent. Unlike recombinant S. mansoni pro-cathepsin B1
expressed in Pichia that requires trans-processing by an endogenous
AE for full activity [30], SmCL3 is already fully processed in Pichia
induction medium at the predicted cleavage site, as judged by
Edman N-terminal sequencing and proteolytic activity. This
suggests that recombinant pro-SmCL3 is capable of auto-catalytic
activation and maturation. Secondly, the SmCL3 zymogen has an
unusually long pro-peptide comprising 130 residues. Approxi-
mately the first 30 amino acids of the pro-peptide share some
homology with the SmCL3 ortholog in S. japonicum and two C.
sinensis cathepsins L. For the SmCL3 prodomain, five helical
structures were predicted which imply some regulatory or
supplementary structural role. Prodomains that are extended N-
terminally, though different in sequence, are also found in the gut-
associated cathepsins L of the animal parasitic nematode
Gnathostoma spinigerum [59] and the plant parasitic nematode
Meloidogyne incognita [60]. These extensions may confer additional
functionality to the zymogen, perhaps in protein trafficking or as
binding sites for other proteins. It is also possible that this
extension may be associated with the fact that the major form of
the enzyme in the parasite apparently exists as a zymogen and/or
the enzyme seems not to be secreted into the gut lumen (see
discussion below).
SmCL3 cleaves albumin and hemoglobin most efficiently at pH
values between 4.0 and 6.0. The pH dependency of hydrolysis of
the Z-Phe-Arg-AMC synthetic substrate results in a bell-shaped
curve from pH 3.5 to 11.0 with an optimum at 6.5. At least 40%
of total activity can be detected between pH 4.0 and 10.0. A
similar bell-shaped pH profile was measured for SmCL1 [46],
which, unlike SmCL2, was able to cleave peptidyl substrate at
basic pH. The acidic pH optima measured against both protein
Figure 12. Sequence relationships among the cathepsin L enzymes. Clustering of cathepsin L sequences accords with the organization of
the kingdoms of life into six super kingdoms [45]: Opisthokonta (light purple and dark blue nodes), Plantae (green), Chromalveolata (red),
Amoebozoa (aquamarine), Rhizaria (single turquoise node) and Excavata (yellow). Circular nodes represent groups of cathepsin L sequences from
platyhelminths and those that are enlarged identify cathepsin L sequences specific to Trematoda. Square nodes depict cathepsin L sequences from
other groups. The white circle represents the sequence from SmCL3 and its S. japonicum ortholog, SjCL3, which are found among the opisthokont,
invertebrate metazoan cathepsin L genes. The large circular node more distant from the main opisthokont cluster corresponds to an inactive
cathepsin L ortholog from S. japonicum (black arrow). The network view identifies a diverse group of cathepsin L sequences making up a cluster
enriched in cathepsin L subtypes cathepsins F and W (encircled in orange) that includes sequences from S. mansoni, S. japonicum, O. viverrini, C.
sinensis, P. westermani and M. yokogawai. Encircled in green are sequences exclusive to the cathepsin H subtype of cysteine cathepsins L. Finally, a
cluster composed solely of baculovirus cathepsin L genes (within the black circle) is least connected to all other sequences in the network.
doi:10.1371/journal.pntd.0000449.g012
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and peptidyl substrates correlates with the pH of the gut lumen
(,pH 6.5) [30,61] and with the lower pH (,4.0) micro-
environments thought to form upon fusion of gut lamellae and
where it is hypothesized that the bulk of gastrodermal proteolysis
by cysteine and aspartic proteases takes place [8].
Recombinant SmCL3 possesses peptidolytic characteristics
consistent with its classification as a Clan CA Family C1 protease:
it is effectively inhibited by the Clan CA-specific inhibitors E-64
and K11777 [32,33], and labeled by the affinity probe DCG-04
[29]. Positional scanning using diverse synthetic substrate libraries
revealed a typical Clan CA preference profile: no single amino
acid preference in S4 and S3 but a strong preference for lysine and
arginine in the S1 subsite [35]. However, in S2 (the subsite driving
specificity in Clan CA proteases), hydrophobic amino acids
(Trp.Tyr.Phe/Val.Leu) are preferred. These preferences at
P2 are similar to those of human cathepsin V [35] but differ, for
example, from F. hepatica cathepsins L1 and L2 that exhibit a
singular preference for Leu and Pro in the case of FhCL2 [62,63].
In support of the S2 preferences demonstrated biochemically with
the PS-SCL, the 3D structural model of SmCL3, using K11777 as
the bound ligand, visualizes a large and deep S2 pocket. The
amino residues forming the S2 pocket are identical to those of
cathepsin V with the exception of one substitution of a Leu
(residue 216) instead of Phe.
SmCL3 is developmentally regulated at both the mRNA and
protein levels being mainly expressed in those stages (schistosom-
ula and adult) infecting the definitive mammalian host and thus
suggesting a function(s) particular to these developmental stages.
That one of these functions is associated with the digestion of host
blood proteins is supported by confocal microscopy using
polyclonal IgG that localizes SmCL3 to gastrodermis of adult
worms. The hypothesis is consistent with the ability of the enzyme
to degrade biologically relevant protein substrates, i.e., hemoglo-
bin and bovine serum albumin, as discussed above. Given that the
transcription of SmCL3 is 50 to1000 fold less than other gut-
associated proteases, the actual proteolytic contribution by
SmCL3 to total proteolysis in the gut remains to be determined.
Because of its localization, it is conceivable that SmCL3
operates with the other gut proteases to complete the degradation
of host proteins as nutrients [7,8]. However, unlike proteases such
as SmCB1, SmCL1 and SmCL2 [30,44,56], SmCL3 was not
detected in worm E/S products when maintained in isotonic
culture medium. However, when adult worms were induced to
regurgitate in water, i.e., exposed to hypotonicity, potentially
causing damage to gut cells, SmCL3 could then be detected by
specific antibody in the regurgitant (data not shown). This suggests
that SmCL3 is normally retained within the gastrodermal
epithelium and is not secreted. Of note is that the G. spinigerum
cathepsin L is likewise not detected in E/S products even though it
is found in the gastrodermis [59]. Apart from the gut, some
immuno-reaction for SmCL3 was also noted in the vitellaria of
female S. mansoni, a finding consistent with the presence of a small
amount of SmCL3 in eggs by immunoblotting. Therefore, SmCL3
may also function in egg and/or miracidial metabolism.
By immunoblotting, SmCL3 was detected in parasite extracts at
a molecular mass of approximately 40 kDa, i.e., consistent with
that of the zymogen. A similar situation was noted recently for the
G. spinigerum cathepsin L – the major species of that enzyme also
migrated at approximately 40 kDa in worm extracts [59].
Attempts to trans-process the SmCL3 zymogen in worm extracts
using other recombinant proteases failed, as did incubating worm
extracts overnight at 37uC. After size-exclusion chromatography of
adult worm extracts, in addition to the resolution of a major
40 kDa protein, minor immuno-reactive protein species were
detected at approximately 28, 15 and 13 kDa. These may
represent the mature deglycosylated enzyme, and two degradation
products, respectively. It seems, therefore, that the major form of
SmCL3 in S. mansoni is a zymogen. The retention of the pro-
peptide with the mature domain opens the possibility of a distinct
function(s) for the zymogen, including the possibility of a limited or
discrete processing activity against protein and peptide substrates.
Precedents for protease zymogens that exhibit peptidolytic activity
exist [30,64]. Often, the strength of the association between the
pro-peptide and mature domain is pH dependent [65], allowing
access to and cleavage of small peptide substrates.
To investigate evolutionary relationships of the full SmCL3
protein sequence and its cathepsin L neighbors, we examined the
top 1,000 hits in a BLAST search of the SmCL3 protein
sequence. We found only 16 other trematode sequences for which
the N-terminus extended far enough to overlap at least 75% of
the prodomain of SmCL3. Most of these sequences were highly
similar to each other and after filtering to 90% identity, there
were only 5 sequences including the SmCL3 sequence. As
expected, a multiple sequence alignment of these sequences
showed a highly conserved catalytic domain, and a more variable
prodomain region (data not shown). In order to visualize more
distant relationships between SmCL3 and cathepsin L-like
sequences, we constructed a SSN using the program Cytoscape
[19]. We have recently established that SSNs show good
agreement with information provided by phylogenetic trees and
allow a clear view of all of the represented proteins in a dataset
together with easy associations to functional and other types of
information [44].
Based on full-length sequences, and as visualized with the
software Cytoscape (Fig. 12), the sequence clustering of cathepsin
L proteins recapitulates the recent proposed partition of Eukarya
into six ‘‘super kingdoms’’ based on multivariate phylogenetic
analyses [45]. SmCL3 is found within the Opisthokonta super
kingdom (that includes animals and fungi). The Opisthokonta
cathepsins L also includes the SjCL3 ortholog from S. japonicum,
SmCL2 [66], and two C. sinensis cathepsins L (Hu et al,
unpublished), as well as a collection of sequences from F. hepatica
and F. gigantica [58]. The network clearly resolves a cluster that is
enriched in cathepsins F/W (encircled in orange) and another
enriched in cathepsin H (encircled in green). This confirms the
previous distinction of the subgroup cathepsins F/W from the
main body of cathepsins L, which arose as a result of gene fusion
between an ancestral cathepsin L and a cystatin (cysteine protease
inhibitor) [67], and from another cathepsin L subgroup, cathepsins
H, which contain a specific mini-chain formation to function as
aminopeptidases [68]. The inclusion within the cathepsin F/W
cluster of SmCL1 (SmCF), other trematodal cathepsins F and the
kinetoplastid cathepsins L supports and extends previous phylo-
genetic data [48,69–71]. Overall, given the close agreement of the
distance relationships observed here between cathepsins L and the
taxonomic separation of the tree of life proposed previously [45],
we would suggest that cathepsins L are useful ‘marker genes’ for
inclusion in future phylogenetic analyses. More in-depth studies of
this and other issues in a global analysis of the members of this
super-family may be enlightening future work.
To conclude, SmL3 is a gut-associated protease with some
unusual sequence and biophysical features. The enzyme may
function as part of the network of proteases [8] that facilitates the
digestion of host proteins by the schistosome parasite. As inhibitors
of Clan CA proteases are therapeutic in animal models of
schistosomiasis [15,16], it is possible that the inhibition of SmCL3,
either alone or in concert with other cysteine proteases, may prove
clinically beneficial.
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Supporting Information
Figure S1 Cystoscape analysis file containing sequences. You
have to download Cytoscape v2.4.1 program at http://www.
cytoscape.org/index.php
Found at: doi:10.1371/journal.pntd.0000449.s001 (0.13 MB ZIP)
Table S1 List of primers used for qPCR analysis
Found at: doi:10.1371/journal.pntd.0000449.s002 (0.05 MB
DOC)
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